Jacobs Levy Equity Management, Inc Y M Abs Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 149,681 shares of YMAB stock, worth $902,576. This represents 0.01% of its overall portfolio holdings.
Number of Shares
149,681
Previous 149,681
-0.0%
Holding current value
$902,576
Previous $1.81 Million
8.68%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding YMAB
# of Institutions
106Shares Held
24.6MCall Options Held
40.3KPut Options Held
400-
Paradigm Biocapital Advisors LP New York, NY4.09MShares$24.6 Million1.93% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$17.7 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$13.2 Million2.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.04MShares$12.3 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$11 Million0.15% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $264M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...